ASLAN Pharmaceuticals Limited

ASLN · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$21,252$56,902$90,168$14,324
Short-Term Investments$0$0$0$0
Receivables$171$0$0$529
Inventory$0$0$0$0
Other Curr. Assets$2,706$3,976$3,613$649
Total Curr. Assets$24,130$60,878$93,781$15,502
Property Plant & Equip (Net)$259$293$233$476
Goodwill$0-$5,830$0$0
Intangibles$2$5,836$0$0
Long-Term Investments$236$9$495$0
Tax Assets-$2-$8,587$0$0
Other NC Assets$2$8,587$0$103
Total NC Assets$497$307$737$579
Other Assets$0$0$0$0
Total Assets$24,627$61,186$94,518$16,082
Liabilities
Payables$7,919$12,784$3,117$2,320
Short-Term Debt$2,027$7,965$199$3,791
Tax Payable$0$0$0$0
Deferred Revenue$0$0$2,818$4,280
Other Curr. Liab.$3,170$2,415$223$267
Total Curr. Liab.$13,115$23,164$6,357$10,657
LT Debt$24,799$29,656$30,857$15,465
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.-$24,799$0$0$112
Total NC Liab.$24,799$29,656$30,857$15,577
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$37,913$52,820$37,214$26,234
Equity
Pref Stock$0$0$0$0
Common Stock$63,932$63,020$63,020$61,826
Retained Earnings-$321,067-$278,387-$227,004-$195,683
AOCI$24,074-$179-$179-$179
Other Equity$219,774$223,911$221,467$123,582
Total Equity-$13,287$8,365$57,304-$10,453
Supplemental Information
Minority Interest$0$0$0$301
Total Liab. & Tot. Equity$24,627$61,186$94,518$16,082
Net Debt$5,573-$19,281-$59,112$4,931